419 related articles for article (PubMed ID: 16469501)
1. Telomeres and telomerase as targets for anticancer drug development.
Olaussen KA; Dubrana K; Domont J; Spano JP; Sabatier L; Soria JC
Crit Rev Oncol Hematol; 2006 Mar; 57(3):191-214. PubMed ID: 16469501
[TBL] [Abstract][Full Text] [Related]
2. [Inhibition of telomeres and telomerase. Seeking for new anticancer drugs].
Raymond E; Faivre S; Dieras V; Von Hoff D
Bull Cancer; 1997 Dec; 84(12):1123-33. PubMed ID: 9587365
[TBL] [Abstract][Full Text] [Related]
3. Targeting telomeres and telomerase.
De Cian A; Lacroix L; Douarre C; Temime-Smaali N; Trentesaux C; Riou JF; Mergny JL
Biochimie; 2008 Jan; 90(1):131-55. PubMed ID: 17822826
[TBL] [Abstract][Full Text] [Related]
4. Telomerase inhibition, oligonucleotides, and clinical trials.
Corey DR
Oncogene; 2002 Jan; 21(4):631-7. PubMed ID: 11850789
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological intervention strategies for affecting telomerase activity: future prospects to treat cancer and degenerative disease.
Tárkányi I; Aradi J
Biochimie; 2008 Jan; 90(1):156-72. PubMed ID: 17945408
[TBL] [Abstract][Full Text] [Related]
6. Telomere biology of pediatric cancer.
Tabori U; Dome JS
Cancer Invest; 2007; 25(3):197-208. PubMed ID: 17530490
[TBL] [Abstract][Full Text] [Related]
7. Telomere maintenance as a target for drug discovery.
Sekaran V; Soares J; Jarstfer MB
J Med Chem; 2014 Feb; 57(3):521-38. PubMed ID: 24053596
[TBL] [Abstract][Full Text] [Related]
8. Telomerase as a target for cancer therapy.
Parkinson KE
Curr Opin Investig Drugs; 2005 Jun; 6(6):605-10. PubMed ID: 15988912
[TBL] [Abstract][Full Text] [Related]
9. Telomerase inhibitors in cancer therapy: current status and future directions.
Incles CM; Schultes CM; Neidle S
Curr Opin Investig Drugs; 2003 Jun; 4(6):675-85. PubMed ID: 12901225
[TBL] [Abstract][Full Text] [Related]
10. Telomere length mediates the effects of telomerase on the cellular response to genotoxic stress.
Rubio MA; Davalos AR; Campisi J
Exp Cell Res; 2004 Aug; 298(1):17-27. PubMed ID: 15242758
[TBL] [Abstract][Full Text] [Related]
11. Overcoming the immortality of tumour cells by telomere and telomerase based cancer therapeutics--current status and future prospects.
Kelland LR
Eur J Cancer; 2005 May; 41(7):971-9. PubMed ID: 15862745
[TBL] [Abstract][Full Text] [Related]
12. Telomerase: a target for cancer therapeutics.
Shay JW; Wright WE
Cancer Cell; 2002 Oct; 2(4):257-65. PubMed ID: 12398889
[TBL] [Abstract][Full Text] [Related]
13. Tackling cancer at the telomeres.
Marx J
Science; 2002 Mar; 295(5564):2350. PubMed ID: 11923505
[No Abstract] [Full Text] [Related]
14. Telomere maintenance as a target for anticancer drug discovery.
Neidle S; Parkinson G
Nat Rev Drug Discov; 2002 May; 1(5):383-93. PubMed ID: 12120414
[TBL] [Abstract][Full Text] [Related]
15. Telomere and telomerase as targets for cancer therapy.
Tian X; Chen B; Liu X
Appl Biochem Biotechnol; 2010 Mar; 160(5):1460-72. PubMed ID: 19412578
[TBL] [Abstract][Full Text] [Related]
16. Complex regulatory mechanisms of telomerase activity in normal and cancer cells: how can we apply them for cancer therapy?
Kyo S; Inoue M
Oncogene; 2002 Jan; 21(4):688-97. PubMed ID: 11850797
[TBL] [Abstract][Full Text] [Related]
17. Telomerase as a therapeutic target for malignant gliomas.
Komata T; Kanzawa T; Kondo Y; Kondo S
Oncogene; 2002 Jan; 21(4):656-63. PubMed ID: 11850793
[TBL] [Abstract][Full Text] [Related]
18. The telomeric PARP, tankyrases, as targets for cancer therapy.
Seimiya H
Br J Cancer; 2006 Feb; 94(3):341-5. PubMed ID: 16421589
[TBL] [Abstract][Full Text] [Related]
19. Telomeres and telomerase: Biological and clinical importance in dogs.
Nasir L
Vet J; 2008 Feb; 175(2):155-63. PubMed ID: 17398127
[TBL] [Abstract][Full Text] [Related]
20. Anticancer therapy targeting telomeres and telomerase : current status.
Parkinson EK; Minty F
BioDrugs; 2007; 21(6):375-85. PubMed ID: 18020621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
